APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 73 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,000 | -41.9% | 90,969 | +3.5% | 0.00% | – |
| Q4 2021 | $167,000 | -50.0% | 87,925 | -20.7% | 0.00% | – |
| Q3 2021 | $334,000 | +24.2% | 110,856 | +61.2% | 0.00% | – |
| Q2 2021 | $269,000 | -26.3% | 68,787 | -4.3% | 0.00% | – |
| Q1 2021 | $365,000 | +324.4% | 71,873 | +307.4% | 0.00% | – |
| Q3 2020 | $86,000 | -38.6% | 17,640 | -58.8% | 0.00% | – |
| Q1 2020 | $140,000 | -37.2% | 42,786 | -28.9% | 0.00% | – |
| Q2 2018 | $223,000 | -69.5% | 60,142 | -58.1% | 0.00% | – |
| Q2 2017 | $732,000 | +771.4% | 143,606 | +1080.3% | 0.00% | – |
| Q1 2017 | $84,000 | -85.2% | 12,167 | -79.9% | 0.00% | – |
| Q4 2016 | $566,000 | -7.8% | 60,482 | -3.6% | 0.00% | – |
| Q3 2016 | $614,000 | -14.6% | 62,750 | +23.4% | 0.00% | – |
| Q2 2016 | $719,000 | +41.0% | 50,868 | +39.3% | 0.00% | – |
| Q1 2016 | $510,000 | +10.2% | 36,511 | +57.7% | 0.00% | – |
| Q1 2015 | $463,000 | -68.0% | 23,146 | -66.3% | 0.00% | – |
| Q4 2014 | $1,446,000 | +391.8% | 68,770 | +440.9% | 0.00% | – |
| Q2 2014 | $294,000 | – | 12,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,404,515 | $1,081,000 | 2.01% |
| SABBY MANAGEMENT, LLC | 811,973 | $625,000 | 0.42% |
| Portolan Capital Management | 1,605,599 | $1,236,000 | 0.12% |
| Knoll Capital Management, LLC | 100,000 | $77,000 | 0.04% |
| Shay Capital LLC | 50,000 | $39,000 | 0.01% |
| COLONY GROUP LLC | 330,287 | $254,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 155,375 | $120,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,499,124 | $1,154,000 | 0.00% |
| Virtu Financial LLC | 10,807 | $8,000 | 0.00% |
| FIDUCIARY TRUST CO | 40,000 | $31,000 | 0.00% |